108 related articles for article (PubMed ID: 32911844)
1. Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Fayyad-Kazan H; Lagneaux L; Bron D; Meuleman N; Lewalle P; Merimi M
Cells; 2020 Sep; 9(9):. PubMed ID: 32911844
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia.
Cieniewicz B; Oliveira E; Saxton M; Torabi D; Bhatta A; Kukutla P; Arballo A; Yang Z; Yu B; Fate M; Ning H; Corey L; Maiti A; Corey D
Clin Cancer Res; 2024 May; 30(9):1878-1888. PubMed ID: 38451195
[TBL] [Abstract][Full Text] [Related]
4. Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.
Binder HM; Maeding N; Wolf M; Cronemberger Andrade A; Vari B; Krisch L; Gomes FG; Blöchl C; Muigg K; Poupardin R; Raninger AM; Heuser T; Obermayer A; Ebner-Peking P; Pleyer L; Greil R; Huber CG; Schallmoser K; Strunk D
Cells; 2021 Nov; 10(12):. PubMed ID: 34943829
[TBL] [Abstract][Full Text] [Related]
5. EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
Zhou Q; Li Z; Xi Y
Exp Hematol; 2024 May; 133():104175. PubMed ID: 38311165
[TBL] [Abstract][Full Text] [Related]
6. Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
Ghetti M; Vannini I; Bochicchio MT; Azzali I; Ledda L; Marconi G; Melloni M; Fabbri F; Rondoni M; Chicchi R; Angeli D; Ghelli Luserna di Rorà A; Giannini B; Zacheo I; Biguzzi R; Lanza F; Martinelli G; Simonetti G
Biomed Pharmacother; 2023 Sep; 165():115235. PubMed ID: 37536029
[TBL] [Abstract][Full Text] [Related]
7. TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice.
Xie X; Zhang W; Xiao M; Wei T; Qiu Y; Qiu J; Wang H; Qiu Z; Zhang S; Pan Y; Mao L; Li Y; Guo B; Yang W; Hu Y; Hu S; Gong Y; Yang J; Xiao G; Zhang Y; Bai X
Blood; 2023 Jun; 141(26):3184-3198. PubMed ID: 37001042
[TBL] [Abstract][Full Text] [Related]
8. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
[TBL] [Abstract][Full Text] [Related]
9. Rational biomarker development for the early and minimally invasive monitoring of AML.
Abdelhamed S; Butler JT; Jung S; Chen DW; Jenkins G; Gao L; Lim JY; Klco JM; Horton TM; Kurre P
Blood Adv; 2021 Nov; 5(21):4515-4520. PubMed ID: 34587228
[TBL] [Abstract][Full Text] [Related]
10. Isolation of lymph shows dysregulation of STAT3 and CREB pathways in the spleen and liver during leukemia development in a rat model.
Steinskog ESS; Finne K; Enger M; Helgeland L; Iversen PO; McCormack E; Wiig H; Tenstad O
Microcirculation; 2023 Apr; 30(2-3):e12800. PubMed ID: 36702790
[TBL] [Abstract][Full Text] [Related]
11. The network structure of hematopoietic cancers.
Nakamura-García AK; Espinal-Enríquez J
Sci Rep; 2023 Nov; 13(1):19837. PubMed ID: 37963971
[TBL] [Abstract][Full Text] [Related]
12. GPR56 in GVL: marker or mechanism?
Iness AN; Bachireddy P
Blood; 2024 Mar; 143(13):1206-1207. PubMed ID: 38546637
[No Abstract] [Full Text] [Related]
13. Delta One T cells recognize AML via DNAM-1.
Kabelitz D
Blood; 2024 Apr; 143(15):1434-1436. PubMed ID: 38602695
[No Abstract] [Full Text] [Related]
14. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis.
Najar M; Martel-Pelletier J; Pelletier JP; Fahmi H
Front Cell Dev Biol; 2020; 8():567813. PubMed ID: 33072752
[TBL] [Abstract][Full Text] [Related]
16. Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles.
Dubois N; Crompot E; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
Front Oncol; 2020; 10():1422. PubMed ID: 32974152
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Lulla PD; Naik S; Vasileiou S; Tzannou I; Watanabe A; Kuvalekar M; Lulla S; Carrum G; Ramos CA; Kamble R; Hill L; Randhawa J; Gottschalk S; Krance R; Wang T; Wu M; Robertson C; Gee AP; Chung B; Grilley B; Brenner MK; Heslop HE; Vera JF; Leen AM
Blood; 2021 May; 137(19):2585-2597. PubMed ID: 33270816
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8
Towers R; Trombello L; Fusenig M; Tunger A; Baumann AL; Savoldelli R; Wehner R; Fasslrinner F; Arndt C; Dazzi F; Von Bonin M; Feldmann A; Bachmann MP; Wobus M; Schmitz M; Bornhäuser M
Cancer Immunol Immunother; 2024 Jan; 73(1):8. PubMed ID: 38231344
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways.
Otmani K; Rouas R; Lagneaux L; Krayem M; Duvillier H; Berehab M; Lewalle P
Cell Commun Signal; 2023 Sep; 21(1):253. PubMed ID: 37735672
[TBL] [Abstract][Full Text] [Related]
20. Exosomes as a Nano-Carrier for Chemotherapeutics: A New Era of Oncology.
Araldi RP; Delvalle DA; da Costa VR; Alievi AL; Teixeira MR; Dias Pinto JR; Kerkis I
Cells; 2023 Aug; 12(17):. PubMed ID: 37681875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
